Drug Interaction Analysis

Why Drug Interactions Matter

Mrs. Lakshmi Devi is a 68-year-old retired school teacher from Hyderabad. She takes metformin and glimepiride for diabetes, amlodipine and telmisartan for blood pressure, atorvastatin for cholesterol, aspirin for her heart, pantoprazole for acidity, and gabapentin for nerve pain in her feet. That is eight medications, prescribed by four different specialists — a diabetologist, a cardiologist, a gastroenterologist, and a neurologist.

None of these doctors have a complete picture of her full medication list. Her cardiologist does not know about the gabapentin. Her gastroenterologist does not know the cardiologist recently added a new blood thinner. Mrs. Devi herself cannot remember half the names — she knows them by colour. "The small white one in the morning, the pink one at night."

This is polypharmacy — the simultaneous use of multiple medications — and it is one of the most dangerous yet underappreciated problems in Indian healthcare. Among elderly patients with chronic conditions like diabetes and hypertension, 5-10 medications is the norm, not the exception.

Types of Drug Interactions

Not all drug interactions are created equal. Understanding the types helps you appreciate what an AI medication review system needs to check.

Pharmacokinetic Interactions (How the Body Processes Drugs)

These occur when one drug affects how the body absorbs, distributes, metabolises, or excretes another drug. Think of it as one drug changing the plumbing that another drug flows through.

Pharmacodynamic Interactions (How Drugs Act on the Body)

These occur when two drugs have additive, synergistic, or opposing effects on the same body system — even though they do not interfere with each other's metabolism.

The Polypharmacy Problem in India

India's polypharmacy challenge has characteristics that differ from Western countries:

Multiple prescribers, no central record — A patient in India typically visits 3-5 specialists independently. Each specialist prescribes without full visibility into what others have prescribed. Unlike countries with integrated EHR systems, India lacks a universal medication list for most patients.

Brand name confusion — The same drug is sold under dozens of brand names in India. Metformin alone is available as Glycomet, Glyciphage, Obimet, Walaphage, and 40+ other brands. A patient might be taking "Glycomet" from one doctor and "Glyciphage" from another — not realising they are doubling up on the same drug.

Over-the-counter availability — Many drugs that require a prescription in Western countries are sold over-the-counter at Indian pharmacies. A patient might buy a painkiller (diclofenac) from a chemist without mentioning it to their doctor — not knowing it interacts with their blood thinner.

Ayurvedic/herbal supplements — Many Indian patients take traditional remedies alongside allopathic medicines. Some of these have real pharmacological effects — for example, ashwagandha can lower blood sugar, and turmeric in high doses can interact with anticoagulants. Patients rarely mention these to their doctors.

> Look at data/prescription-samples.json for the polypharmacy case studies used in the sandbox exercises.

How AI Checks Interactions at Scale

An AI-powered medication review system works in three layers, each catching different types of problems:

Layer 1: Pairwise Drug-Drug Interaction Check

The AI takes the complete medication list and checks every possible pair of drugs against an interaction database. For a patient on 8 medications, that is 28 unique pairs to check. For a patient on 12 medications, it is 66 pairs. This combinatorial explosion is exactly why humans miss interactions — no doctor can hold 66 pairwise checks in their head during a 10-minute consultation.

Layer 2: Drug-Disease Interaction Check

Some drugs are dangerous not because of other drugs, but because of the patient's conditions. For example:

Layer 3: Duplicate Therapy Detection

The AI identifies when a patient is taking two drugs from the same class — a surprisingly common problem when multiple specialists prescribe independently. Examples:

> Look at data/drug-interactions.json for the interaction database used in the sandbox medication review tool.

Indian Brand Names vs Generic Names

One of the biggest practical challenges for medication review AI in India is the brand name problem. Here is a real-world example of how confusing this gets:

A patient might tell you: "I take Glycomet, Amlong, Atorva, Pan, Telma, Clopilet, and Met XL." The AI must resolve every brand name to its generic equivalent before it can check interactions. This requires a comprehensive Indian drug formulary — not just a global database.

A Real-World Interaction Scenario

Let us walk through what an AI medication review looks like in practice, using Mrs. Lakshmi Devi's case from the beginning:

Her medications:

AI Findings:

The AI flags these interactions, ranks them by severity, and presents them to the reviewing doctor or pharmacist. It does not stop the prescription — it informs the decision.

The Role of the Pharmacist

In Indian healthcare, pharmacists are an underutilised safety net. In many countries, pharmacists routinely review medication lists for interactions before dispensing. In India, this rarely happens — the chemist shop dispenses whatever is written on the prescription, often without even reading the full list.

AI-powered medication review at the pharmacy counter could be transformative. When a patient hands over prescriptions from three different doctors, the pharmacist's software automatically:

This does not require the pharmacist to be a clinical pharmacology expert. The AI does the heavy lifting. The pharmacist applies judgement and communicates with the patient and doctor.

Key Takeaways